+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Terminated

Phase Not Applicable
Age: 18Years +
All Genders
ID06217939

Early Intravenous Hydrocortisone in Sepsis a Randomized Control Trial

Led by Siriraj Hospital · Updated on 2026-07-28

116

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What this Trial Is About

The goal of this clinical trial is to compare two timings of steroid treatment in patients with severe infection who develop low blood pressure. The main question it aims to answer is: • Which timing strategy is better between starting steroid treatment very early in the course of severe infection, or waiting until the patient does not respond to medicine that raises blood pressure according to the current guidelines? Participants will receive either early steroid treatment or placebo right after they develop low blood pressure from infection. Both participants and treating doctors will not know which treatment participants received. When blood pressure goal is not reached after a moderate dose of drugs that raise blood pressure, an open-label steroid treatment will be given to participants as indicated in the current guidelines.

CONDITIONS

Brief Title

Early Intravenous Hydrocortisone in Sepsis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here